Catecholamines block 2-hydroxyestradiol-induced antimitogenesis in mesangial cells.

Area of Science:

• Nephrology
• Endocrinology
• Cell Biology

Background:

• 2-hydroxyestradiol inhibits glomerular mesangial cell (GMC) growth.
• Catechol-O-methyl transferase (COMT) methylates 2-hydroxyestradiol to 2-methoxyestradiol, mediating its antimitogenic effects.
• GMCs express COMT, and catecholamines are COMT substrates.

Purpose of the Study:

• To investigate if catecholamines abrogate the antimitogenic effects of 2-hydroxyestradiol on GMCs.
• To determine if catecholamines compete with 2-hydroxyestradiol for COMT, inhibiting 2-methoxyestradiol formation.
• To evaluate the impact of catecholamines on 2-hydroxyestradiol's effects on GMC proliferation and extracellular matrix synthesis.

Main Methods:

• Cultured rat GMCs were treated with 2-hydroxyestradiol in the presence and absence of catecholamines (norepinephrine, epinephrine).
• GMC metabolism of 2-hydroxyestradiol was assessed, including Vmax and Km.
• Inhibition of 3H-thymidine incorporation (DNA synthesis), cell number, and 3H-proline incorporation (collagen synthesis) were measured.

Main Results:

• GMCs metabolized 2-hydroxyestradiol in a concentration-dependent manner.
• Norepinephrine and epinephrine significantly inhibited 2-hydroxyestradiol methylation by GMCs.
• Catecholamines abrogated the inhibitory effects of 2-hydroxyestradiol on GMC DNA synthesis, proliferation, and collagen synthesis.

Conclusions:

• Methylation of 2-hydroxyestradiol by COMT inhibits GMC proliferation and extracellular matrix synthesis, potentially protecting against renal diseases.
• Catecholamines interfere with this protective mechanism by competing for COMT, thus reducing 2-methoxyestradiol formation.
• This interaction may explain how catecholamines abrogate the renoprotective effects of 2-hydroxyestradiol in the glomeruli.